P14.83 Adjuvant chemotherapy after severe myelotoxicity during temozolomide chemoradiation in gliomas. It is feasibile? The talian Multicentric Study (AINO)

BACKGROUND: Malignant gliomas are aggressive primitive brain tumor in adults. Today, the standard of care is Temozolomide (TMZ) administered daily with radiation therapy, followed by adjuvant TMZ. TMZ treatment has been considered to have a low toxicity profile. However, during concomitant treatment...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuro Oncol
Hauptverfasser: Villani, V, Fabi, A, Gaviani, P, Rudà, R, Lombardi, G, Simonetti, G, Silvani, A, Pronello, E, Minniti, G, Pace, A
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2019
Schlagworte:
Poster Presentations
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6796058/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz126.318
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge